Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses
- 1 December 2001
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 108 (6) , 1027-1032
- https://doi.org/10.1067/mai.2001.119154
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosisJournal of Internal Medicine, 1993
- Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safetyJournal of Allergy and Clinical Immunology, 1992
- Evolution of sensitivity to Hymenoptera venom in 200 allergic patients followed for up to 3 yearsJournal of Allergy and Clinical Immunology, 1989
- Schnellhyposensibilisierung mit Hymenopterengiften: Verträglichkeit und TherapieerfolgDeutsche Medizinische Wochenschrift (1946), 1987
- Immunotherapy with Yellow Jacket VenomAllergy, 1986
- Discontinuation of bee venom immunotherapy in children and adolescentsThe Journal of Pediatrics, 1985
- Rush venom immunotherapy: a 3‐day programme for hymenoptera sting allergyClinical and Experimental Allergy, 1984
- Dose dependence of Hymenoptera venom immunotherapyPublished by Elsevier ,1981
- Diagnosis and treatment of anaphylactic reactions to Hymenoptera stings in childrenThe Journal of Pediatrics, 1980
- INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTESPublished by Elsevier ,1977